Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

The U.S. Food and Drug Administration on Friday approved three new natural food color additives, part of Department of Health ...

Lars Fruergaard Jørgensen, the boss of Danish pharmaceutical giant Novo Nordisk, explained what impact the drugs can have on users weight in the long run ...

Here's what Casey Means, President Trump's pick for surgeon general has said about childhood vaccines, pesticides, autism and ...

Chances are, you haven’t heard of metabolic dysfunction–associated steatohepatitis (MASH)—but you’ve almost definitely heard ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis ...

Rebel Wilson opened up about how her weight loss journey has impacted her professional life, explaining that since losing 80 ...

"Revolutionary" anti-obesity drugs like Ozempic appear to be the right tool to deal with the addictive, highly processed ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Novo Nordisk also announced that it has filed regulatory applications seeking approval for the oral version of Wegovy (25mg) for the treatment of obesity. Novo Nordisk is the first company to seek ...

Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...

We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...